Equity Overview
Price & Market Data
Price: $4.73
Daily Change: -$0.56 / 11.84%
Range: $4.53 - $6.49
Market Cap: $17,451,490
Volume: 165,771
Performance Metrics
1 Week: -18.29%
1 Month: 51.78%
3 Months: 48.42%
6 Months: -50.86%
1 Year: -82.75%
YTD: -45.21%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.